Elevated systemic levels and locally increased expression of IL26 have been reported in chronic inflammatory diseases like Crohn’s disease, rheumatoid arthritis, SpA, psoriasis and ANCA-associated vasculitis (11, 13–16). This evidence concerns the gene IL26 and psoriasis.